Monte Rosa Therapeutics Inc (GLUE) — Cash Flow Reinvestment Rate
Monte Rosa Therapeutics Inc (GLUE) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting $38.79 Million (capex $651.00K plus investments $38.14 Million) from operating cash flow of $100.43 Million. See GLUE cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Monte Rosa Therapeutics Inc Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for Monte Rosa Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see GLUE cash flow metrics.
Annual Cash Flow Reinvestment Rate for Monte Rosa Therapeutics Inc (2024–2024)
Year-by-year capital reinvestment analysis for Monte Rosa Therapeutics Inc. See GLUE financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.15x | $48.44 Million | $42.00 Million | $3.99 Million | — |